• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RUBICON 35; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RUBICON 35; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 39540
Device Problem Material Perforation (2205)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/23/2020
Event Type  malfunction  
Event Description
It was reported that a catheter perforation occurred.The target lesion was located in the moderately tortuous and moderately calcified right iliac arterial stent and left angiogram.A 90cm rubicon 18 guide catheter was selected for use.During the procedure, after removal of the device from the patient's body, it was discovered that the wire inside the catheter penetrated through the rubicon catheter.The wire was visibly out of the catheter.The procedure was completed using multiple catheters of various types.No complications were reported and the patient was fine post procedure.
 
Event Description
It was reported that a catheter perforation occurred.The target lesion was located in the moderately tortuous and moderately calcified right iliac arterial stent and left angiogram.A 90cm rubicon 18 guide catheter was selected for use.During the procedure, after removal of the device from the patient's body, it was discovered that the wire inside the catheter penetrated through the rubicon catheter.The wire was visibly out of the catheter.The procedure was completed using multiple catheters of various types.No complications were reported and the patient was fine post procedure.It was further reported that a 90cm rubicon 35 guide catheter was selected for use.
 
Manufacturer Narrative
Device evaluated by mfr: the device was returned for analysis.There was blood and contrast in the device.Analysis of the tip, shaft, and hub relief included microscopic and visual inspection.Inspection revealed a shaft kink located 5.9cm from the tip, and shaft damage (hole/perforation) located 10.2cm from the tip.Inspection of the rest of the device found no other damage or defect.The reported shaft perforation was confirmed.
 
Event Description
It was reported that a catheter perforation occurred.The target lesion was located in the moderately tortuous and moderately calcified right iliac arterial stent and left angiogram.A 90cm rubicon 18 guide catheter was selected for use.During the procedure, after removal of the device from the patient's body, it was discovered that the wire inside the catheter penetrated through the rubicon catheter.The wire was visibly out of the catheter.The procedure was completed using multiple catheters of various types.No complications were reported and the patient was fine post procedure.It was further reported that a 90cm rubicon 35 guide catheter was selected for use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUBICON 35
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10942043
MDR Text Key219506096
Report Number2134265-2020-16851
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
PMA/PMN Number
K122394
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 01/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/07/2023
Device Model Number39540
Device Catalogue Number39540
Device Lot Number0025830027
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/13/2020
Initial Date Manufacturer Received 11/24/2020
Initial Date FDA Received12/03/2020
Supplement Dates Manufacturer Received12/04/2020
01/14/2021
Supplement Dates FDA Received12/14/2020
01/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-